Evaluation of Antiatherogenic Properties of Ezetimibe Using (3)H-Labeled Low-Density-Lipoprotein Cholesterol and (99m)Tc-cAbVCAM1-5 SPECT in ApoE(-/-) Mice Fed the Paigen Diet.

Dumas LS, Briand F, Clerc R, Brousseau E, Montemagno C, Ahmadi M, Bacot S, Soubies A, Perret P, Riou LM, Devoogdt N, Lahoutte T, Barone-Rochette G, Fagret D, Ghezzi C, Sulpice T, Broisat A

Open source

DOI: 10.2967/jnumed.116.177279
Published: 2017 Jul
Container: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2967/jnumed.116.177279,
  title = {Evaluation of Antiatherogenic Properties of Ezetimibe Using (3)H-Labeled Low-Density-Lipoprotein Cholesterol and (99m)Tc-cAbVCAM1-5 SPECT in ApoE(-/-) Mice Fed the Paigen Diet.},
  author = {Dumas LS and Briand F and Clerc R and Brousseau E and Montemagno C and Ahmadi M and Bacot S and Soubies A and Perret P and Riou LM and Devoogdt N and Lahoutte T and Barone-Rochette G and Fagret D and Ghezzi C and Sulpice T and Broisat A},
  year = {2017},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  doi = {10.2967/jnumed.116.177279},
  url = {https://doi.org/10.2967/jnumed.116.177279}
}

RIS

TY  - JOUR
TI  - Evaluation of Antiatherogenic Properties of Ezetimibe Using (3)H-Labeled Low-Density-Lipoprotein Cholesterol and (99m)Tc-cAbVCAM1-5 SPECT in ApoE(-/-) Mice Fed the Paigen Diet.
AU  - Dumas LS
AU  - Briand F
AU  - Clerc R
AU  - Brousseau E
AU  - Montemagno C
AU  - Ahmadi M
AU  - Bacot S
AU  - Soubies A
AU  - Perret P
AU  - Riou LM
AU  - Devoogdt N
AU  - Lahoutte T
AU  - Barone-Rochette G
AU  - Fagret D
AU  - Ghezzi C
AU  - Sulpice T
AU  - Broisat A
PY  - 2017
JO  - Journal of nuclear medicine : official publication, Society of Nuclear Medicine
DO  - 10.2967/jnumed.116.177279
UR  - https://doi.org/10.2967/jnumed.116.177279
ER  -

APA

LS, D., F, B., R, C., E, B., C, M., M, A., S, B., A, S., P, P., LM, R., N, D., T, L., G, B., D, F., C, G., T, S., & A, B. (2017). Evaluation of Antiatherogenic Properties of Ezetimibe Using (3)H-Labeled Low-Density-Lipoprotein Cholesterol and (99m)Tc-cAbVCAM1-5 SPECT in ApoE(-/-) Mice Fed the Paigen Diet.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. https://doi.org/10.2967/jnumed.116.177279

Source records

pubmed · retrieved 2026-09-26T22:41:37.750Z